tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

KRYS Stock Latest News

Optimistic Buy Rating for Krystal Biotech Driven by Innovative Gene Therapy KB801 for Neurotrophic Keratitis
RatingsOptimistic Buy Rating for Krystal Biotech Driven by Innovative Gene Therapy KB801 for Neurotrophic Keratitis
9d ago
KRYS
Krystal Biotech price target raised to $176 from $155 at Citi
PremiumThe Fly
Krystal Biotech price target raised to $176 from $155 at Citi
9d ago
KRYS
Cautious Optimism for Krystal Biotech’s KB801 Amidst Uncertain Efficacy Data
PremiumRatings
Cautious Optimism for Krystal Biotech’s KB801 Amidst Uncertain Efficacy Data
9d ago
KRYS
Promising Market Potential and Innovative Approach Drive Buy Rating for Krystal Biotech’s Gene Therapy KB801
PremiumRatings
Promising Market Potential and Innovative Approach Drive Buy Rating for Krystal Biotech’s Gene Therapy KB801
9d ago
KRYS
Krystal Biotech Begins Phase 1/2 Trial for KB801
PremiumCompany Announcements
Krystal Biotech Begins Phase 1/2 Trial for KB801
9d ago
8K
KRYS
Krystal Biotech announces first patient dosed in Phase 1/2 trial of KB801
PremiumThe FlyKrystal Biotech announces first patient dosed in Phase 1/2 trial of KB801
9d ago
KRYS
Krystal Biotech reports assay results from Phase 2 drill program in Namibia
Premium
The Fly
Krystal Biotech reports assay results from Phase 2 drill program in Namibia
9d ago
KRYS
3 Best Stocks to Buy Now, 7/1/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 7/1/2025, According to Top Analysts
17d ago
MU
KRYS
Krystal Biotech initiated with a Buy at Clear Street
PremiumThe Fly
Krystal Biotech initiated with a Buy at Clear Street
18d ago
KRYS
Krystal Biotech’s Promising Pipeline and Strategic Expansions Drive Buy Rating
PremiumRatings
Krystal Biotech’s Promising Pipeline and Strategic Expansions Drive Buy Rating
18d ago
KRYS
Promising Developments in Krystal Biotech’s Gene Therapy Drive Buy Rating
PremiumRatings
Promising Developments in Krystal Biotech’s Gene Therapy Drive Buy Rating
24d ago
KRYS
Krystal Biotech announces first patient dosed in Phase 3 trial of KB803
PremiumThe Fly
Krystal Biotech announces first patient dosed in Phase 3 trial of KB803
24d ago
KRYS
Krystal Biotech’s Promising Growth and Strategic Initiatives Support Buy Rating
PremiumRatingsKrystal Biotech’s Promising Growth and Strategic Initiatives Support Buy Rating
1M ago
KRYS
Promising Clinical Data and Strategic Advancements Drive Buy Rating for Krystal Biotech
Premium
Ratings
Promising Clinical Data and Strategic Advancements Drive Buy Rating for Krystal Biotech
2M ago
KRYS
Krystal Biotech Reports Promising Results for KB707 Trial
Premium
Company Announcements
Krystal Biotech Reports Promising Results for KB707 Trial
2M ago
8K
KRYS
Krystal Biotech Holds Annual Stockholders Meeting
PremiumCompany Announcements
Krystal Biotech Holds Annual Stockholders Meeting
2M ago
8K
KRYS
Krystal Biotech: Hold Rating Amid Slowed Growth and Conservative Pipeline Outlook
PremiumRatings
Krystal Biotech: Hold Rating Amid Slowed Growth and Conservative Pipeline Outlook
2M ago
KRYS
Krystal Biotech price target lowered to $155 from $215 at Citi
PremiumThe Fly
Krystal Biotech price target lowered to $155 from $215 at Citi
2M ago
KRYS
Krystal Biotech’s Gene Therapy Expansion: Promising Preclinical Results and Long-term Value Proposition
PremiumRatings
Krystal Biotech’s Gene Therapy Expansion: Promising Preclinical Results and Long-term Value Proposition
2M ago
KRYS
Krystal Biotech Expands Gene Therapy Platform
PremiumCompany AnnouncementsKrystal Biotech Expands Gene Therapy Platform
2M ago
8K
KRYS
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
PTN
BOLT
Krystal Biotech price target lowered to $189 from $195 at Guggenheim
Premium
The Fly
Krystal Biotech price target lowered to $189 from $195 at Guggenheim
2M ago
KRYS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >